1. Cheong, Hyun Sub, Lee, Jeong-Hoon, Yu, Su Jong, Shin, Hyoung Doo, Kim, Yoon-Jun. 2015. Association of VARS2-SFTA2 polymorphisms with the risk of chronic hepatitis B in a Korean population. In Liver international : official journal of the International Association for the Study of the Liver, 35, 1934-40. doi:10.1111/liv.12740. https://pubmed.ncbi.nlm.nih.gov/25404243/
2. Mittal, Rashmi A, Hammel, Markus, Schwarz, Johannes, Eickelberg, Oliver, Holzinger, Andreas. 2012. SFTA2--a novel secretory peptide highly expressed in the lung--is modulated by lipopolysaccharide but not hyperoxia. In PloS one, 7, e40011. doi:10.1371/journal.pone.0040011. https://pubmed.ncbi.nlm.nih.gov/22768197/
3. Li, Na, Zhai, Zhanqiang, Chen, Yuanbiao, Li, Xiaofeng. 2022. Transcriptomic and immunologic implications of the epithelial-mesenchymal transition model reveal a novel role of SFTA2 in prognosis of non-small-cell lung carcinoma. In Frontiers in genetics, 13, 911801. doi:10.3389/fgene.2022.911801. https://pubmed.ncbi.nlm.nih.gov/36092941/
4. Khadzhieva, M B, Kuzovlev, A N, Salnikova, L E. 2019. Pneumonia: host susceptibility and shared genetics with pulmonary function and other traits. In Clinical and experimental immunology, 198, 367-380. doi:10.1111/cei.13367. https://pubmed.ncbi.nlm.nih.gov/31487037/
5. Li, Ye, Hu, Mingliang, Zhang, Zhigang, Qiu, Qiang, Wang, Kun. 2025. Origin and stepwise evolution of vertebrate lungs. In Nature ecology & evolution, , . doi:10.1038/s41559-025-02642-6. https://pubmed.ncbi.nlm.nih.gov/39953253/
6. Man, Yuxin, Xin, Dao, Ji, Yang, Kou, Lingna, Jiang, Lingxi. 2024. Identification and validation of a novel six-gene signature based on mucinous adenocarcinoma-related gene molecular typing in colorectal cancer. In Discover oncology, 15, 63. doi:10.1007/s12672-024-00916-2. https://pubmed.ncbi.nlm.nih.gov/38443703/
7. Huang, Qian, Peng, Xingyu, Li, Qingqing, Xue, Ju, Jiang, Hua. 2023. Construction and comprehensive analysis of a novel prognostic signature associated with pyroptosis molecular subtypes in patients with pancreatic adenocarcinoma. In Frontiers in immunology, 14, 1111494. doi:10.3389/fimmu.2023.1111494. https://pubmed.ncbi.nlm.nih.gov/36817451/